PH25545A - Sustained release multi-granule tablet - Google Patents

Sustained release multi-granule tablet

Info

Publication number
PH25545A
PH25545A PH35625A PH35625A PH25545A PH 25545 A PH25545 A PH 25545A PH 35625 A PH35625 A PH 35625A PH 35625 A PH35625 A PH 35625A PH 25545 A PH25545 A PH 25545A
Authority
PH
Philippines
Prior art keywords
sustained release
tablet
formulation adjuvant
release multi
sustained
Prior art date
Application number
PH35625A
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Muyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH25545A publication Critical patent/PH25545A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH35625A 1986-08-06 1987-08-05 Sustained release multi-granule tablet PH25545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤

Publications (1)

Publication Number Publication Date
PH25545A true PH25545A (en) 1991-08-08

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35625A PH25545A (en) 1986-08-06 1987-08-05 Sustained release multi-granule tablet

Country Status (11)

Country Link
EP (1) EP0255725B1 (de)
JP (1) JPH0780754B2 (de)
KR (1) KR950002148B1 (de)
AT (1) ATE102480T1 (de)
CA (1) CA1315680C (de)
DE (1) DE3789258T2 (de)
DK (1) DK175798B1 (de)
ES (1) ES2050653T3 (de)
FI (1) FI96480C (de)
NO (1) NO178134C (de)
PH (1) PH25545A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
WO1995010264A1 (en) * 1993-10-12 1995-04-20 Tokyo Tanabe Company Limited Tablet containing enteric granules
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
ES2351249T3 (es) 2001-07-27 2011-02-02 Astellas Pharma Inc. Composición que comprende partículas finas, de liberación sostenida, para comprimidos de disgregación rápida en la cavidad bucal.
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
FI96480B (fi) 1996-03-29
ES2050653T3 (es) 1994-06-01
DK175798B1 (da) 2005-02-28
CA1315680C (en) 1993-04-06
EP0255725A2 (de) 1988-02-10
NO178134C (no) 1996-01-31
NO178134B (no) 1995-10-23
DK407287A (da) 1988-02-07
FI96480C (fi) 1996-07-10
FI873407L (fi) 1988-02-07
JPS6339811A (ja) 1988-02-20
EP0255725A3 (de) 1991-01-30
JPH0780754B2 (ja) 1995-08-30
DE3789258T2 (de) 1994-08-11
KR950002148B1 (ko) 1995-03-14
FI873407A0 (fi) 1987-08-05
DK407287D0 (da) 1987-08-05
EP0255725B1 (de) 1994-03-09
DE3789258D1 (de) 1994-04-14
ATE102480T1 (de) 1994-03-15
NO873273D0 (no) 1987-08-05
NO873273L (no) 1988-02-08
KR880002510A (ko) 1988-05-09

Similar Documents

Publication Publication Date Title
IL88083A0 (en) Controlled release pharmaceutical dosage form and its preparation
SE8504720D0 (sv) New drug preparation
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
JPS649930A (en) Device for drug control release
DE3776982D1 (de) Arzneimittel mit gesteuerter absorption.
PH25545A (en) Sustained release multi-granule tablet
CA2034096A1 (en) Controlled absorption naproxen formulation for once-daily administration
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
CA2024502A1 (en) Dosage form for administering oral hypoglycemic glipizide
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
ATE44130T1 (de) Pharmazeutische produkte mit einem gehalt an magnesiumtrisilikat-adsorbens mit darauf adsorbiertem heilmittelwirkstoff.
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
NO865195L (no) FremgangsmŸte for fremstilling av et retardpreparat av ibuprofen.
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
ATE87467T1 (de) Pharmazeutische zubereitung.
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
GB1379008A (en) Medicament for the treatment of herpes simplex
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
NO873805L (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
MY102184A (en) New drug preparation with controlled release of the active compound, a method for the manufacture thereof and the use of the new preparation
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.